Pharma giant Merck has gone to the dogs! Or, at least, its Merck Animal Health business. A new twist on the company’s two-year-old “Bravo, Bravecto!” ad campaign provides a dog’s perspective on ...
MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced ...
(RTTNews) - Merck Animal Health, a division of Merck & Co., Inc. (MRK), announced the U.S. Food and Drug Administration's approval of an expanded indication for BRAVECTO Chews for Dogs. . The new ...
Merck Animal Health announced the US Food and Drug Administration’s (FDA) approval of Bravecto 1-Month (fluralaner) chews for dogs and puppies 8 weeks of age and older. The product is administered as ...
12-Month Parasiticide Treatment for Dogs Offers Unrivaled Duration of Flea and Tick Protection Compared to Existing Products BRAVECTO QUANTUM was first approved in Australia and New Zealand in 2023, ...
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs ...
BRAVECTO 1-MONTH is an important addition to the company’s parasiticide portfolio, which are extended duration flea and tick protection products that offer broad-spectrum, comprehensive parasite ...
MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results